Global Rare Disease Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Rare Disease Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Rare Disease Drug industry chain, the market status of Hospital Pharmacies (Above 1‰, 0.65‰?1‰), Speciality Pharmacies (Above 1‰, 0.65‰?1‰), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Rare Disease Drug.
Regionally, the report analyzes the Rare Disease Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Rare Disease Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Rare Disease Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Rare Disease Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Doses), revenue generated, and market share of different by Type (e.g., Above 1‰, 0.65‰?1‰).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Rare Disease Drug market.
Regional Analysis: The report involves examining the Rare Disease Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Rare Disease Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Rare Disease Drug:
Company Analysis: Report covers individual Rare Disease Drug manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Rare Disease Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacies, Speciality Pharmacies).
Technology Analysis: Report covers specific technologies relevant to Rare Disease Drug. It assesses the current state, advancements, and potential future developments in Rare Disease Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Rare Disease Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Rare Disease Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Rare Disease Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Rare Disease Drug, with price, sales, revenue and global market share of Rare Disease Drug from 2019 to 2024.
Chapter 3, the Rare Disease Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rare Disease Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Rare Disease Drug market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Rare Disease Drug.
Chapter 14 and 15, to describe Rare Disease Drug sales channel, distributors, customers, research findings and conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Rare Disease Drug industry chain, the market status of Hospital Pharmacies (Above 1‰, 0.65‰?1‰), Speciality Pharmacies (Above 1‰, 0.65‰?1‰), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Rare Disease Drug.
Regionally, the report analyzes the Rare Disease Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Rare Disease Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Rare Disease Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Rare Disease Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Doses), revenue generated, and market share of different by Type (e.g., Above 1‰, 0.65‰?1‰).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Rare Disease Drug market.
Regional Analysis: The report involves examining the Rare Disease Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Rare Disease Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Rare Disease Drug:
Company Analysis: Report covers individual Rare Disease Drug manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Rare Disease Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacies, Speciality Pharmacies).
Technology Analysis: Report covers specific technologies relevant to Rare Disease Drug. It assesses the current state, advancements, and potential future developments in Rare Disease Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Rare Disease Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Rare Disease Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Above 1‰
- 0.65‰?1‰
- Below 0.1‰
- Hospital Pharmacies
- Speciality Pharmacies
- Retail pharmacies
- Others
- Novartis AG
- Bristol-Myers Squibb Company
- Celgene Corporation
- F. Hoffmann-La Roche Ltd.
- Pfizer, Inc.
- Sanofi S.A.
- Alexion Pharmaceuticals, Inc.
- Eli Lilly and Company
- Novo Nordisk A/S
- AstraZeneca
- Eisai Co., Ltd.
- Daiichi Sankyo Company Limited
- Bayer AG
- GlaxoSmithKline
- Merck & Co., Inc.
- Johnson & Johnson
- Biogen, Inc.
- Takeda
- Amgen, Inc.
- Deciphera
- Atara Biotherapeutics
- ProQR
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Rare Disease Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Rare Disease Drug, with price, sales, revenue and global market share of Rare Disease Drug from 2019 to 2024.
Chapter 3, the Rare Disease Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rare Disease Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Rare Disease Drug market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Rare Disease Drug.
Chapter 14 and 15, to describe Rare Disease Drug sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Rare Disease Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Rare Disease Drug Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Above 1‰
1.3.3 0.65‰?1‰
1.3.4 Below 0.1‰
1.4 Market Analysis by Application
1.4.1 Overview: Global Rare Disease Drug Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital Pharmacies
1.4.3 Speciality Pharmacies
1.4.4 Retail pharmacies
1.4.5 Others
1.5 Global Rare Disease Drug Market Size & Forecast
1.5.1 Global Rare Disease Drug Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Rare Disease Drug Sales Quantity (2019-2030)
1.5.3 Global Rare Disease Drug Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business
2.1.3 Novartis AG Rare Disease Drug Product and Services
2.1.4 Novartis AG Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Novartis AG Recent Developments/Updates
2.2 Bristol-Myers Squibb Company
2.2.1 Bristol-Myers Squibb Company Details
2.2.2 Bristol-Myers Squibb Company Major Business
2.2.3 Bristol-Myers Squibb Company Rare Disease Drug Product and Services
2.2.4 Bristol-Myers Squibb Company Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Bristol-Myers Squibb Company Recent Developments/Updates
2.3 Celgene Corporation
2.3.1 Celgene Corporation Details
2.3.2 Celgene Corporation Major Business
2.3.3 Celgene Corporation Rare Disease Drug Product and Services
2.3.4 Celgene Corporation Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Celgene Corporation Recent Developments/Updates
2.4 F. Hoffmann-La Roche Ltd.
2.4.1 F. Hoffmann-La Roche Ltd. Details
2.4.2 F. Hoffmann-La Roche Ltd. Major Business
2.4.3 F. Hoffmann-La Roche Ltd. Rare Disease Drug Product and Services
2.4.4 F. Hoffmann-La Roche Ltd. Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
2.5 Pfizer, Inc.
2.5.1 Pfizer, Inc. Details
2.5.2 Pfizer, Inc. Major Business
2.5.3 Pfizer, Inc. Rare Disease Drug Product and Services
2.5.4 Pfizer, Inc. Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Pfizer, Inc. Recent Developments/Updates
2.6 Sanofi S.A.
2.6.1 Sanofi S.A. Details
2.6.2 Sanofi S.A. Major Business
2.6.3 Sanofi S.A. Rare Disease Drug Product and Services
2.6.4 Sanofi S.A. Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Sanofi S.A. Recent Developments/Updates
2.7 Alexion Pharmaceuticals, Inc.
2.7.1 Alexion Pharmaceuticals, Inc. Details
2.7.2 Alexion Pharmaceuticals, Inc. Major Business
2.7.3 Alexion Pharmaceuticals, Inc. Rare Disease Drug Product and Services
2.7.4 Alexion Pharmaceuticals, Inc. Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Alexion Pharmaceuticals, Inc. Recent Developments/Updates
2.8 Eli Lilly and Company
2.8.1 Eli Lilly and Company Details
2.8.2 Eli Lilly and Company Major Business
2.8.3 Eli Lilly and Company Rare Disease Drug Product and Services
2.8.4 Eli Lilly and Company Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Eli Lilly and Company Recent Developments/Updates
2.9 Novo Nordisk A/S
2.9.1 Novo Nordisk A/S Details
2.9.2 Novo Nordisk A/S Major Business
2.9.3 Novo Nordisk A/S Rare Disease Drug Product and Services
2.9.4 Novo Nordisk A/S Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Novo Nordisk A/S Recent Developments/Updates
2.10 AstraZeneca
2.10.1 AstraZeneca Details
2.10.2 AstraZeneca Major Business
2.10.3 AstraZeneca Rare Disease Drug Product and Services
2.10.4 AstraZeneca Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 AstraZeneca Recent Developments/Updates
2.11 Eisai Co., Ltd.
2.11.1 Eisai Co., Ltd. Details
2.11.2 Eisai Co., Ltd. Major Business
2.11.3 Eisai Co., Ltd. Rare Disease Drug Product and Services
2.11.4 Eisai Co., Ltd. Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Eisai Co., Ltd. Recent Developments/Updates
2.12 Daiichi Sankyo Company Limited
2.12.1 Daiichi Sankyo Company Limited Details
2.12.2 Daiichi Sankyo Company Limited Major Business
2.12.3 Daiichi Sankyo Company Limited Rare Disease Drug Product and Services
2.12.4 Daiichi Sankyo Company Limited Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Daiichi Sankyo Company Limited Recent Developments/Updates
2.13 Bayer AG
2.13.1 Bayer AG Details
2.13.2 Bayer AG Major Business
2.13.3 Bayer AG Rare Disease Drug Product and Services
2.13.4 Bayer AG Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Bayer AG Recent Developments/Updates
2.14 GlaxoSmithKline
2.14.1 GlaxoSmithKline Details
2.14.2 GlaxoSmithKline Major Business
2.14.3 GlaxoSmithKline Rare Disease Drug Product and Services
2.14.4 GlaxoSmithKline Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 GlaxoSmithKline Recent Developments/Updates
2.15 Merck & Co., Inc.
2.15.1 Merck & Co., Inc. Details
2.15.2 Merck & Co., Inc. Major Business
2.15.3 Merck & Co., Inc. Rare Disease Drug Product and Services
2.15.4 Merck & Co., Inc. Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Merck & Co., Inc. Recent Developments/Updates
2.16 Johnson & Johnson
2.16.1 Johnson & Johnson Details
2.16.2 Johnson & Johnson Major Business
2.16.3 Johnson & Johnson Rare Disease Drug Product and Services
2.16.4 Johnson & Johnson Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Johnson & Johnson Recent Developments/Updates
2.17 Biogen, Inc.
2.17.1 Biogen, Inc. Details
2.17.2 Biogen, Inc. Major Business
2.17.3 Biogen, Inc. Rare Disease Drug Product and Services
2.17.4 Biogen, Inc. Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Biogen, Inc. Recent Developments/Updates
2.18 Takeda
2.18.1 Takeda Details
2.18.2 Takeda Major Business
2.18.3 Takeda Rare Disease Drug Product and Services
2.18.4 Takeda Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Takeda Recent Developments/Updates
2.19 Amgen, Inc.
2.19.1 Amgen, Inc. Details
2.19.2 Amgen, Inc. Major Business
2.19.3 Amgen, Inc. Rare Disease Drug Product and Services
2.19.4 Amgen, Inc. Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Amgen, Inc. Recent Developments/Updates
2.20 Deciphera
2.20.1 Deciphera Details
2.20.2 Deciphera Major Business
2.20.3 Deciphera Rare Disease Drug Product and Services
2.20.4 Deciphera Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Deciphera Recent Developments/Updates
2.21 Atara Biotherapeutics
2.21.1 Atara Biotherapeutics Details
2.21.2 Atara Biotherapeutics Major Business
2.21.3 Atara Biotherapeutics Rare Disease Drug Product and Services
2.21.4 Atara Biotherapeutics Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 Atara Biotherapeutics Recent Developments/Updates
2.22 ProQR
2.22.1 ProQR Details
2.22.2 ProQR Major Business
2.22.3 ProQR Rare Disease Drug Product and Services
2.22.4 ProQR Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.22.5 ProQR Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: RARE DISEASE DRUG BY MANUFACTURER
3.1 Global Rare Disease Drug Sales Quantity by Manufacturer (2019-2024)
3.2 Global Rare Disease Drug Revenue by Manufacturer (2019-2024)
3.3 Global Rare Disease Drug Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Rare Disease Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Rare Disease Drug Manufacturer Market Share in 2023
3.4.2 Top 6 Rare Disease Drug Manufacturer Market Share in 2023
3.5 Rare Disease Drug Market: Overall Company Footprint Analysis
3.5.1 Rare Disease Drug Market: Region Footprint
3.5.2 Rare Disease Drug Market: Company Product Type Footprint
3.5.3 Rare Disease Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Rare Disease Drug Market Size by Region
4.1.1 Global Rare Disease Drug Sales Quantity by Region (2019-2030)
4.1.2 Global Rare Disease Drug Consumption Value by Region (2019-2030)
4.1.3 Global Rare Disease Drug Average Price by Region (2019-2030)
4.2 North America Rare Disease Drug Consumption Value (2019-2030)
4.3 Europe Rare Disease Drug Consumption Value (2019-2030)
4.4 Asia-Pacific Rare Disease Drug Consumption Value (2019-2030)
4.5 South America Rare Disease Drug Consumption Value (2019-2030)
4.6 Middle East and Africa Rare Disease Drug Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Rare Disease Drug Sales Quantity by Type (2019-2030)
5.2 Global Rare Disease Drug Consumption Value by Type (2019-2030)
5.3 Global Rare Disease Drug Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Rare Disease Drug Sales Quantity by Application (2019-2030)
6.2 Global Rare Disease Drug Consumption Value by Application (2019-2030)
6.3 Global Rare Disease Drug Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Rare Disease Drug Sales Quantity by Type (2019-2030)
7.2 North America Rare Disease Drug Sales Quantity by Application (2019-2030)
7.3 North America Rare Disease Drug Market Size by Country
7.3.1 North America Rare Disease Drug Sales Quantity by Country (2019-2030)
7.3.2 North America Rare Disease Drug Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Rare Disease Drug Sales Quantity by Type (2019-2030)
8.2 Europe Rare Disease Drug Sales Quantity by Application (2019-2030)
8.3 Europe Rare Disease Drug Market Size by Country
8.3.1 Europe Rare Disease Drug Sales Quantity by Country (2019-2030)
8.3.2 Europe Rare Disease Drug Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Rare Disease Drug Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Rare Disease Drug Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Rare Disease Drug Market Size by Region
9.3.1 Asia-Pacific Rare Disease Drug Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Rare Disease Drug Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Rare Disease Drug Sales Quantity by Type (2019-2030)
10.2 South America Rare Disease Drug Sales Quantity by Application (2019-2030)
10.3 South America Rare Disease Drug Market Size by Country
10.3.1 South America Rare Disease Drug Sales Quantity by Country (2019-2030)
10.3.2 South America Rare Disease Drug Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Rare Disease Drug Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Rare Disease Drug Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Rare Disease Drug Market Size by Country
11.3.1 Middle East & Africa Rare Disease Drug Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Rare Disease Drug Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Rare Disease Drug Market Drivers
12.2 Rare Disease Drug Market Restraints
12.3 Rare Disease Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Rare Disease Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Rare Disease Drug
13.3 Rare Disease Drug Production Process
13.4 Rare Disease Drug Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Rare Disease Drug Typical Distributors
14.3 Rare Disease Drug Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Rare Disease Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Rare Disease Drug Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Above 1‰
1.3.3 0.65‰?1‰
1.3.4 Below 0.1‰
1.4 Market Analysis by Application
1.4.1 Overview: Global Rare Disease Drug Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital Pharmacies
1.4.3 Speciality Pharmacies
1.4.4 Retail pharmacies
1.4.5 Others
1.5 Global Rare Disease Drug Market Size & Forecast
1.5.1 Global Rare Disease Drug Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Rare Disease Drug Sales Quantity (2019-2030)
1.5.3 Global Rare Disease Drug Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business
2.1.3 Novartis AG Rare Disease Drug Product and Services
2.1.4 Novartis AG Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Novartis AG Recent Developments/Updates
2.2 Bristol-Myers Squibb Company
2.2.1 Bristol-Myers Squibb Company Details
2.2.2 Bristol-Myers Squibb Company Major Business
2.2.3 Bristol-Myers Squibb Company Rare Disease Drug Product and Services
2.2.4 Bristol-Myers Squibb Company Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Bristol-Myers Squibb Company Recent Developments/Updates
2.3 Celgene Corporation
2.3.1 Celgene Corporation Details
2.3.2 Celgene Corporation Major Business
2.3.3 Celgene Corporation Rare Disease Drug Product and Services
2.3.4 Celgene Corporation Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Celgene Corporation Recent Developments/Updates
2.4 F. Hoffmann-La Roche Ltd.
2.4.1 F. Hoffmann-La Roche Ltd. Details
2.4.2 F. Hoffmann-La Roche Ltd. Major Business
2.4.3 F. Hoffmann-La Roche Ltd. Rare Disease Drug Product and Services
2.4.4 F. Hoffmann-La Roche Ltd. Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
2.5 Pfizer, Inc.
2.5.1 Pfizer, Inc. Details
2.5.2 Pfizer, Inc. Major Business
2.5.3 Pfizer, Inc. Rare Disease Drug Product and Services
2.5.4 Pfizer, Inc. Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Pfizer, Inc. Recent Developments/Updates
2.6 Sanofi S.A.
2.6.1 Sanofi S.A. Details
2.6.2 Sanofi S.A. Major Business
2.6.3 Sanofi S.A. Rare Disease Drug Product and Services
2.6.4 Sanofi S.A. Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Sanofi S.A. Recent Developments/Updates
2.7 Alexion Pharmaceuticals, Inc.
2.7.1 Alexion Pharmaceuticals, Inc. Details
2.7.2 Alexion Pharmaceuticals, Inc. Major Business
2.7.3 Alexion Pharmaceuticals, Inc. Rare Disease Drug Product and Services
2.7.4 Alexion Pharmaceuticals, Inc. Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Alexion Pharmaceuticals, Inc. Recent Developments/Updates
2.8 Eli Lilly and Company
2.8.1 Eli Lilly and Company Details
2.8.2 Eli Lilly and Company Major Business
2.8.3 Eli Lilly and Company Rare Disease Drug Product and Services
2.8.4 Eli Lilly and Company Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Eli Lilly and Company Recent Developments/Updates
2.9 Novo Nordisk A/S
2.9.1 Novo Nordisk A/S Details
2.9.2 Novo Nordisk A/S Major Business
2.9.3 Novo Nordisk A/S Rare Disease Drug Product and Services
2.9.4 Novo Nordisk A/S Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Novo Nordisk A/S Recent Developments/Updates
2.10 AstraZeneca
2.10.1 AstraZeneca Details
2.10.2 AstraZeneca Major Business
2.10.3 AstraZeneca Rare Disease Drug Product and Services
2.10.4 AstraZeneca Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 AstraZeneca Recent Developments/Updates
2.11 Eisai Co., Ltd.
2.11.1 Eisai Co., Ltd. Details
2.11.2 Eisai Co., Ltd. Major Business
2.11.3 Eisai Co., Ltd. Rare Disease Drug Product and Services
2.11.4 Eisai Co., Ltd. Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Eisai Co., Ltd. Recent Developments/Updates
2.12 Daiichi Sankyo Company Limited
2.12.1 Daiichi Sankyo Company Limited Details
2.12.2 Daiichi Sankyo Company Limited Major Business
2.12.3 Daiichi Sankyo Company Limited Rare Disease Drug Product and Services
2.12.4 Daiichi Sankyo Company Limited Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Daiichi Sankyo Company Limited Recent Developments/Updates
2.13 Bayer AG
2.13.1 Bayer AG Details
2.13.2 Bayer AG Major Business
2.13.3 Bayer AG Rare Disease Drug Product and Services
2.13.4 Bayer AG Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Bayer AG Recent Developments/Updates
2.14 GlaxoSmithKline
2.14.1 GlaxoSmithKline Details
2.14.2 GlaxoSmithKline Major Business
2.14.3 GlaxoSmithKline Rare Disease Drug Product and Services
2.14.4 GlaxoSmithKline Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 GlaxoSmithKline Recent Developments/Updates
2.15 Merck & Co., Inc.
2.15.1 Merck & Co., Inc. Details
2.15.2 Merck & Co., Inc. Major Business
2.15.3 Merck & Co., Inc. Rare Disease Drug Product and Services
2.15.4 Merck & Co., Inc. Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Merck & Co., Inc. Recent Developments/Updates
2.16 Johnson & Johnson
2.16.1 Johnson & Johnson Details
2.16.2 Johnson & Johnson Major Business
2.16.3 Johnson & Johnson Rare Disease Drug Product and Services
2.16.4 Johnson & Johnson Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Johnson & Johnson Recent Developments/Updates
2.17 Biogen, Inc.
2.17.1 Biogen, Inc. Details
2.17.2 Biogen, Inc. Major Business
2.17.3 Biogen, Inc. Rare Disease Drug Product and Services
2.17.4 Biogen, Inc. Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Biogen, Inc. Recent Developments/Updates
2.18 Takeda
2.18.1 Takeda Details
2.18.2 Takeda Major Business
2.18.3 Takeda Rare Disease Drug Product and Services
2.18.4 Takeda Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Takeda Recent Developments/Updates
2.19 Amgen, Inc.
2.19.1 Amgen, Inc. Details
2.19.2 Amgen, Inc. Major Business
2.19.3 Amgen, Inc. Rare Disease Drug Product and Services
2.19.4 Amgen, Inc. Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Amgen, Inc. Recent Developments/Updates
2.20 Deciphera
2.20.1 Deciphera Details
2.20.2 Deciphera Major Business
2.20.3 Deciphera Rare Disease Drug Product and Services
2.20.4 Deciphera Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Deciphera Recent Developments/Updates
2.21 Atara Biotherapeutics
2.21.1 Atara Biotherapeutics Details
2.21.2 Atara Biotherapeutics Major Business
2.21.3 Atara Biotherapeutics Rare Disease Drug Product and Services
2.21.4 Atara Biotherapeutics Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 Atara Biotherapeutics Recent Developments/Updates
2.22 ProQR
2.22.1 ProQR Details
2.22.2 ProQR Major Business
2.22.3 ProQR Rare Disease Drug Product and Services
2.22.4 ProQR Rare Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.22.5 ProQR Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: RARE DISEASE DRUG BY MANUFACTURER
3.1 Global Rare Disease Drug Sales Quantity by Manufacturer (2019-2024)
3.2 Global Rare Disease Drug Revenue by Manufacturer (2019-2024)
3.3 Global Rare Disease Drug Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Rare Disease Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Rare Disease Drug Manufacturer Market Share in 2023
3.4.2 Top 6 Rare Disease Drug Manufacturer Market Share in 2023
3.5 Rare Disease Drug Market: Overall Company Footprint Analysis
3.5.1 Rare Disease Drug Market: Region Footprint
3.5.2 Rare Disease Drug Market: Company Product Type Footprint
3.5.3 Rare Disease Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Rare Disease Drug Market Size by Region
4.1.1 Global Rare Disease Drug Sales Quantity by Region (2019-2030)
4.1.2 Global Rare Disease Drug Consumption Value by Region (2019-2030)
4.1.3 Global Rare Disease Drug Average Price by Region (2019-2030)
4.2 North America Rare Disease Drug Consumption Value (2019-2030)
4.3 Europe Rare Disease Drug Consumption Value (2019-2030)
4.4 Asia-Pacific Rare Disease Drug Consumption Value (2019-2030)
4.5 South America Rare Disease Drug Consumption Value (2019-2030)
4.6 Middle East and Africa Rare Disease Drug Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Rare Disease Drug Sales Quantity by Type (2019-2030)
5.2 Global Rare Disease Drug Consumption Value by Type (2019-2030)
5.3 Global Rare Disease Drug Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Rare Disease Drug Sales Quantity by Application (2019-2030)
6.2 Global Rare Disease Drug Consumption Value by Application (2019-2030)
6.3 Global Rare Disease Drug Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Rare Disease Drug Sales Quantity by Type (2019-2030)
7.2 North America Rare Disease Drug Sales Quantity by Application (2019-2030)
7.3 North America Rare Disease Drug Market Size by Country
7.3.1 North America Rare Disease Drug Sales Quantity by Country (2019-2030)
7.3.2 North America Rare Disease Drug Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Rare Disease Drug Sales Quantity by Type (2019-2030)
8.2 Europe Rare Disease Drug Sales Quantity by Application (2019-2030)
8.3 Europe Rare Disease Drug Market Size by Country
8.3.1 Europe Rare Disease Drug Sales Quantity by Country (2019-2030)
8.3.2 Europe Rare Disease Drug Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Rare Disease Drug Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Rare Disease Drug Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Rare Disease Drug Market Size by Region
9.3.1 Asia-Pacific Rare Disease Drug Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Rare Disease Drug Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Rare Disease Drug Sales Quantity by Type (2019-2030)
10.2 South America Rare Disease Drug Sales Quantity by Application (2019-2030)
10.3 South America Rare Disease Drug Market Size by Country
10.3.1 South America Rare Disease Drug Sales Quantity by Country (2019-2030)
10.3.2 South America Rare Disease Drug Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Rare Disease Drug Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Rare Disease Drug Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Rare Disease Drug Market Size by Country
11.3.1 Middle East & Africa Rare Disease Drug Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Rare Disease Drug Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Rare Disease Drug Market Drivers
12.2 Rare Disease Drug Market Restraints
12.3 Rare Disease Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Rare Disease Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Rare Disease Drug
13.3 Rare Disease Drug Production Process
13.4 Rare Disease Drug Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Rare Disease Drug Typical Distributors
14.3 Rare Disease Drug Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Rare Disease Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Rare Disease Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 4. Novartis AG Major Business
Table 5. Novartis AG Rare Disease Drug Product and Services
Table 6. Novartis AG Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Novartis AG Recent Developments/Updates
Table 8. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 9. Bristol-Myers Squibb Company Major Business
Table 10. Bristol-Myers Squibb Company Rare Disease Drug Product and Services
Table 11. Bristol-Myers Squibb Company Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Bristol-Myers Squibb Company Recent Developments/Updates
Table 13. Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table 14. Celgene Corporation Major Business
Table 15. Celgene Corporation Rare Disease Drug Product and Services
Table 16. Celgene Corporation Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Celgene Corporation Recent Developments/Updates
Table 18. F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table 19. F. Hoffmann-La Roche Ltd. Major Business
Table 20. F. Hoffmann-La Roche Ltd. Rare Disease Drug Product and Services
Table 21. F. Hoffmann-La Roche Ltd. Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 23. Pfizer, Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer, Inc. Major Business
Table 25. Pfizer, Inc. Rare Disease Drug Product and Services
Table 26. Pfizer, Inc. Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Pfizer, Inc. Recent Developments/Updates
Table 28. Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table 29. Sanofi S.A. Major Business
Table 30. Sanofi S.A. Rare Disease Drug Product and Services
Table 31. Sanofi S.A. Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Sanofi S.A. Recent Developments/Updates
Table 33. Alexion Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 34. Alexion Pharmaceuticals, Inc. Major Business
Table 35. Alexion Pharmaceuticals, Inc. Rare Disease Drug Product and Services
Table 36. Alexion Pharmaceuticals, Inc. Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Alexion Pharmaceuticals, Inc. Recent Developments/Updates
Table 38. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 39. Eli Lilly and Company Major Business
Table 40. Eli Lilly and Company Rare Disease Drug Product and Services
Table 41. Eli Lilly and Company Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Eli Lilly and Company Recent Developments/Updates
Table 43. Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
Table 44. Novo Nordisk A/S Major Business
Table 45. Novo Nordisk A/S Rare Disease Drug Product and Services
Table 46. Novo Nordisk A/S Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Novo Nordisk A/S Recent Developments/Updates
Table 48. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 49. AstraZeneca Major Business
Table 50. AstraZeneca Rare Disease Drug Product and Services
Table 51. AstraZeneca Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. AstraZeneca Recent Developments/Updates
Table 53. Eisai Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 54. Eisai Co., Ltd. Major Business
Table 55. Eisai Co., Ltd. Rare Disease Drug Product and Services
Table 56. Eisai Co., Ltd. Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Eisai Co., Ltd. Recent Developments/Updates
Table 58. Daiichi Sankyo Company Limited Basic Information, Manufacturing Base and Competitors
Table 59. Daiichi Sankyo Company Limited Major Business
Table 60. Daiichi Sankyo Company Limited Rare Disease Drug Product and Services
Table 61. Daiichi Sankyo Company Limited Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Daiichi Sankyo Company Limited Recent Developments/Updates
Table 63. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 64. Bayer AG Major Business
Table 65. Bayer AG Rare Disease Drug Product and Services
Table 66. Bayer AG Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Bayer AG Recent Developments/Updates
Table 68. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 69. GlaxoSmithKline Major Business
Table 70. GlaxoSmithKline Rare Disease Drug Product and Services
Table 71. GlaxoSmithKline Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. GlaxoSmithKline Recent Developments/Updates
Table 73. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 74. Merck & Co., Inc. Major Business
Table 75. Merck & Co., Inc. Rare Disease Drug Product and Services
Table 76. Merck & Co., Inc. Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Merck & Co., Inc. Recent Developments/Updates
Table 78. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 79. Johnson & Johnson Major Business
Table 80. Johnson & Johnson Rare Disease Drug Product and Services
Table 81. Johnson & Johnson Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Johnson & Johnson Recent Developments/Updates
Table 83. Biogen, Inc. Basic Information, Manufacturing Base and Competitors
Table 84. Biogen, Inc. Major Business
Table 85. Biogen, Inc. Rare Disease Drug Product and Services
Table 86. Biogen, Inc. Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. Biogen, Inc. Recent Developments/Updates
Table 88. Takeda Basic Information, Manufacturing Base and Competitors
Table 89. Takeda Major Business
Table 90. Takeda Rare Disease Drug Product and Services
Table 91. Takeda Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. Takeda Recent Developments/Updates
Table 93. Amgen, Inc. Basic Information, Manufacturing Base and Competitors
Table 94. Amgen, Inc. Major Business
Table 95. Amgen, Inc. Rare Disease Drug Product and Services
Table 96. Amgen, Inc. Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 97. Amgen, Inc. Recent Developments/Updates
Table 98. Deciphera Basic Information, Manufacturing Base and Competitors
Table 99. Deciphera Major Business
Table 100. Deciphera Rare Disease Drug Product and Services
Table 101. Deciphera Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 102. Deciphera Recent Developments/Updates
Table 103. Atara Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 104. Atara Biotherapeutics Major Business
Table 105. Atara Biotherapeutics Rare Disease Drug Product and Services
Table 106. Atara Biotherapeutics Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Atara Biotherapeutics Recent Developments/Updates
Table 108. ProQR Basic Information, Manufacturing Base and Competitors
Table 109. ProQR Major Business
Table 110. ProQR Rare Disease Drug Product and Services
Table 111. ProQR Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 112. ProQR Recent Developments/Updates
Table 113. Global Rare Disease Drug Sales Quantity by Manufacturer (2019-2024) & (K Doses)
Table 114. Global Rare Disease Drug Revenue by Manufacturer (2019-2024) & (USD Million)
Table 115. Global Rare Disease Drug Average Price by Manufacturer (2019-2024) & (USD/Dose)
Table 116. Market Position of Manufacturers in Rare Disease Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 117. Head Office and Rare Disease Drug Production Site of Key Manufacturer
Table 118. Rare Disease Drug Market: Company Product Type Footprint
Table 119. Rare Disease Drug Market: Company Product Application Footprint
Table 120. Rare Disease Drug New Market Entrants and Barriers to Market Entry
Table 121. Rare Disease Drug Mergers, Acquisition, Agreements, and Collaborations
Table 122. Global Rare Disease Drug Sales Quantity by Region (2019-2024) & (K Doses)
Table 123. Global Rare Disease Drug Sales Quantity by Region (2025-2030) & (K Doses)
Table 124. Global Rare Disease Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 125. Global Rare Disease Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 126. Global Rare Disease Drug Average Price by Region (2019-2024) & (USD/Dose)
Table 127. Global Rare Disease Drug Average Price by Region (2025-2030) & (USD/Dose)
Table 128. Global Rare Disease Drug Sales Quantity by Type (2019-2024) & (K Doses)
Table 129. Global Rare Disease Drug Sales Quantity by Type (2025-2030) & (K Doses)
Table 130. Global Rare Disease Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 131. Global Rare Disease Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 132. Global Rare Disease Drug Average Price by Type (2019-2024) & (USD/Dose)
Table 133. Global Rare Disease Drug Average Price by Type (2025-2030) & (USD/Dose)
Table 134. Global Rare Disease Drug Sales Quantity by Application (2019-2024) & (K Doses)
Table 135. Global Rare Disease Drug Sales Quantity by Application (2025-2030) & (K Doses)
Table 136. Global Rare Disease Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 137. Global Rare Disease Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 138. Global Rare Disease Drug Average Price by Application (2019-2024) & (USD/Dose)
Table 139. Global Rare Disease Drug Average Price by Application (2025-2030) & (USD/Dose)
Table 140. North America Rare Disease Drug Sales Quantity by Type (2019-2024) & (K Doses)
Table 141. North America Rare Disease Drug Sales Quantity by Type (2025-2030) & (K Doses)
Table 142. North America Rare Disease Drug Sales Quantity by Application (2019-2024) & (K Doses)
Table 143. North America Rare Disease Drug Sales Quantity by Application (2025-2030) & (K Doses)
Table 144. North America Rare Disease Drug Sales Quantity by Country (2019-2024) & (K Doses)
Table 145. North America Rare Disease Drug Sales Quantity by Country (2025-2030) & (K Doses)
Table 146. North America Rare Disease Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 147. North America Rare Disease Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 148. Europe Rare Disease Drug Sales Quantity by Type (2019-2024) & (K Doses)
Table 149. Europe Rare Disease Drug Sales Quantity by Type (2025-2030) & (K Doses)
Table 150. Europe Rare Disease Drug Sales Quantity by Application (2019-2024) & (K Doses)
Table 151. Europe Rare Disease Drug Sales Quantity by Application (2025-2030) & (K Doses)
Table 152. Europe Rare Disease Drug Sales Quantity by Country (2019-2024) & (K Doses)
Table 153. Europe Rare Disease Drug Sales Quantity by Country (2025-2030) & (K Doses)
Table 154. Europe Rare Disease Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 155. Europe Rare Disease Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 156. Asia-Pacific Rare Disease Drug Sales Quantity by Type (2019-2024) & (K Doses)
Table 157. Asia-Pacific Rare Disease Drug Sales Quantity by Type (2025-2030) & (K Doses)
Table 158. Asia-Pacific Rare Disease Drug Sales Quantity by Application (2019-2024) & (K Doses)
Table 159. Asia-Pacific Rare Disease Drug Sales Quantity by Application (2025-2030) & (K Doses)
Table 160. Asia-Pacific Rare Disease Drug Sales Quantity by Region (2019-2024) & (K Doses)
Table 161. Asia-Pacific Rare Disease Drug Sales Quantity by Region (2025-2030) & (K Doses)
Table 162. Asia-Pacific Rare Disease Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 163. Asia-Pacific Rare Disease Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 164. South America Rare Disease Drug Sales Quantity by Type (2019-2024) & (K Doses)
Table 165. South America Rare Disease Drug Sales Quantity by Type (2025-2030) & (K Doses)
Table 166. South America Rare Disease Drug Sales Quantity by Application (2019-2024) & (K Doses)
Table 167. South America Rare Disease Drug Sales Quantity by Application (2025-2030) & (K Doses)
Table 168. South America Rare Disease Drug Sales Quantity by Country (2019-2024) & (K Doses)
Table 169. South America Rare Disease Drug Sales Quantity by Country (2025-2030) & (K Doses)
Table 170. South America Rare Disease Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 171. South America Rare Disease Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 172. Middle East & Africa Rare Disease Drug Sales Quantity by Type (2019-2024) & (K Doses)
Table 173. Middle East & Africa Rare Disease Drug Sales Quantity by Type (2025-2030) & (K Doses)
Table 174. Middle East & Africa Rare Disease Drug Sales Quantity by Application (2019-2024) & (K Doses)
Table 175. Middle East & Africa Rare Disease Drug Sales Quantity by Application (2025-2030) & (K Doses)
Table 176. Middle East & Africa Rare Disease Drug Sales Quantity by Region (2019-2024) & (K Doses)
Table 177. Middle East & Africa Rare Disease Drug Sales Quantity by Region (2025-2030) & (K Doses)
Table 178. Middle East & Africa Rare Disease Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 179. Middle East & Africa Rare Disease Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 180. Rare Disease Drug Raw Material
Table 181. Key Manufacturers of Rare Disease Drug Raw Materials
Table 182. Rare Disease Drug Typical Distributors
Table 183. Rare Disease Drug Typical Customers
Table 1. Global Rare Disease Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Rare Disease Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 4. Novartis AG Major Business
Table 5. Novartis AG Rare Disease Drug Product and Services
Table 6. Novartis AG Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Novartis AG Recent Developments/Updates
Table 8. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 9. Bristol-Myers Squibb Company Major Business
Table 10. Bristol-Myers Squibb Company Rare Disease Drug Product and Services
Table 11. Bristol-Myers Squibb Company Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Bristol-Myers Squibb Company Recent Developments/Updates
Table 13. Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table 14. Celgene Corporation Major Business
Table 15. Celgene Corporation Rare Disease Drug Product and Services
Table 16. Celgene Corporation Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Celgene Corporation Recent Developments/Updates
Table 18. F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table 19. F. Hoffmann-La Roche Ltd. Major Business
Table 20. F. Hoffmann-La Roche Ltd. Rare Disease Drug Product and Services
Table 21. F. Hoffmann-La Roche Ltd. Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 23. Pfizer, Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer, Inc. Major Business
Table 25. Pfizer, Inc. Rare Disease Drug Product and Services
Table 26. Pfizer, Inc. Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Pfizer, Inc. Recent Developments/Updates
Table 28. Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table 29. Sanofi S.A. Major Business
Table 30. Sanofi S.A. Rare Disease Drug Product and Services
Table 31. Sanofi S.A. Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Sanofi S.A. Recent Developments/Updates
Table 33. Alexion Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 34. Alexion Pharmaceuticals, Inc. Major Business
Table 35. Alexion Pharmaceuticals, Inc. Rare Disease Drug Product and Services
Table 36. Alexion Pharmaceuticals, Inc. Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Alexion Pharmaceuticals, Inc. Recent Developments/Updates
Table 38. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 39. Eli Lilly and Company Major Business
Table 40. Eli Lilly and Company Rare Disease Drug Product and Services
Table 41. Eli Lilly and Company Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Eli Lilly and Company Recent Developments/Updates
Table 43. Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
Table 44. Novo Nordisk A/S Major Business
Table 45. Novo Nordisk A/S Rare Disease Drug Product and Services
Table 46. Novo Nordisk A/S Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Novo Nordisk A/S Recent Developments/Updates
Table 48. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 49. AstraZeneca Major Business
Table 50. AstraZeneca Rare Disease Drug Product and Services
Table 51. AstraZeneca Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. AstraZeneca Recent Developments/Updates
Table 53. Eisai Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 54. Eisai Co., Ltd. Major Business
Table 55. Eisai Co., Ltd. Rare Disease Drug Product and Services
Table 56. Eisai Co., Ltd. Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Eisai Co., Ltd. Recent Developments/Updates
Table 58. Daiichi Sankyo Company Limited Basic Information, Manufacturing Base and Competitors
Table 59. Daiichi Sankyo Company Limited Major Business
Table 60. Daiichi Sankyo Company Limited Rare Disease Drug Product and Services
Table 61. Daiichi Sankyo Company Limited Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Daiichi Sankyo Company Limited Recent Developments/Updates
Table 63. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 64. Bayer AG Major Business
Table 65. Bayer AG Rare Disease Drug Product and Services
Table 66. Bayer AG Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Bayer AG Recent Developments/Updates
Table 68. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 69. GlaxoSmithKline Major Business
Table 70. GlaxoSmithKline Rare Disease Drug Product and Services
Table 71. GlaxoSmithKline Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. GlaxoSmithKline Recent Developments/Updates
Table 73. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 74. Merck & Co., Inc. Major Business
Table 75. Merck & Co., Inc. Rare Disease Drug Product and Services
Table 76. Merck & Co., Inc. Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Merck & Co., Inc. Recent Developments/Updates
Table 78. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 79. Johnson & Johnson Major Business
Table 80. Johnson & Johnson Rare Disease Drug Product and Services
Table 81. Johnson & Johnson Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Johnson & Johnson Recent Developments/Updates
Table 83. Biogen, Inc. Basic Information, Manufacturing Base and Competitors
Table 84. Biogen, Inc. Major Business
Table 85. Biogen, Inc. Rare Disease Drug Product and Services
Table 86. Biogen, Inc. Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. Biogen, Inc. Recent Developments/Updates
Table 88. Takeda Basic Information, Manufacturing Base and Competitors
Table 89. Takeda Major Business
Table 90. Takeda Rare Disease Drug Product and Services
Table 91. Takeda Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. Takeda Recent Developments/Updates
Table 93. Amgen, Inc. Basic Information, Manufacturing Base and Competitors
Table 94. Amgen, Inc. Major Business
Table 95. Amgen, Inc. Rare Disease Drug Product and Services
Table 96. Amgen, Inc. Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 97. Amgen, Inc. Recent Developments/Updates
Table 98. Deciphera Basic Information, Manufacturing Base and Competitors
Table 99. Deciphera Major Business
Table 100. Deciphera Rare Disease Drug Product and Services
Table 101. Deciphera Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 102. Deciphera Recent Developments/Updates
Table 103. Atara Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 104. Atara Biotherapeutics Major Business
Table 105. Atara Biotherapeutics Rare Disease Drug Product and Services
Table 106. Atara Biotherapeutics Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Atara Biotherapeutics Recent Developments/Updates
Table 108. ProQR Basic Information, Manufacturing Base and Competitors
Table 109. ProQR Major Business
Table 110. ProQR Rare Disease Drug Product and Services
Table 111. ProQR Rare Disease Drug Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 112. ProQR Recent Developments/Updates
Table 113. Global Rare Disease Drug Sales Quantity by Manufacturer (2019-2024) & (K Doses)
Table 114. Global Rare Disease Drug Revenue by Manufacturer (2019-2024) & (USD Million)
Table 115. Global Rare Disease Drug Average Price by Manufacturer (2019-2024) & (USD/Dose)
Table 116. Market Position of Manufacturers in Rare Disease Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 117. Head Office and Rare Disease Drug Production Site of Key Manufacturer
Table 118. Rare Disease Drug Market: Company Product Type Footprint
Table 119. Rare Disease Drug Market: Company Product Application Footprint
Table 120. Rare Disease Drug New Market Entrants and Barriers to Market Entry
Table 121. Rare Disease Drug Mergers, Acquisition, Agreements, and Collaborations
Table 122. Global Rare Disease Drug Sales Quantity by Region (2019-2024) & (K Doses)
Table 123. Global Rare Disease Drug Sales Quantity by Region (2025-2030) & (K Doses)
Table 124. Global Rare Disease Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 125. Global Rare Disease Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 126. Global Rare Disease Drug Average Price by Region (2019-2024) & (USD/Dose)
Table 127. Global Rare Disease Drug Average Price by Region (2025-2030) & (USD/Dose)
Table 128. Global Rare Disease Drug Sales Quantity by Type (2019-2024) & (K Doses)
Table 129. Global Rare Disease Drug Sales Quantity by Type (2025-2030) & (K Doses)
Table 130. Global Rare Disease Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 131. Global Rare Disease Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 132. Global Rare Disease Drug Average Price by Type (2019-2024) & (USD/Dose)
Table 133. Global Rare Disease Drug Average Price by Type (2025-2030) & (USD/Dose)
Table 134. Global Rare Disease Drug Sales Quantity by Application (2019-2024) & (K Doses)
Table 135. Global Rare Disease Drug Sales Quantity by Application (2025-2030) & (K Doses)
Table 136. Global Rare Disease Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 137. Global Rare Disease Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 138. Global Rare Disease Drug Average Price by Application (2019-2024) & (USD/Dose)
Table 139. Global Rare Disease Drug Average Price by Application (2025-2030) & (USD/Dose)
Table 140. North America Rare Disease Drug Sales Quantity by Type (2019-2024) & (K Doses)
Table 141. North America Rare Disease Drug Sales Quantity by Type (2025-2030) & (K Doses)
Table 142. North America Rare Disease Drug Sales Quantity by Application (2019-2024) & (K Doses)
Table 143. North America Rare Disease Drug Sales Quantity by Application (2025-2030) & (K Doses)
Table 144. North America Rare Disease Drug Sales Quantity by Country (2019-2024) & (K Doses)
Table 145. North America Rare Disease Drug Sales Quantity by Country (2025-2030) & (K Doses)
Table 146. North America Rare Disease Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 147. North America Rare Disease Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 148. Europe Rare Disease Drug Sales Quantity by Type (2019-2024) & (K Doses)
Table 149. Europe Rare Disease Drug Sales Quantity by Type (2025-2030) & (K Doses)
Table 150. Europe Rare Disease Drug Sales Quantity by Application (2019-2024) & (K Doses)
Table 151. Europe Rare Disease Drug Sales Quantity by Application (2025-2030) & (K Doses)
Table 152. Europe Rare Disease Drug Sales Quantity by Country (2019-2024) & (K Doses)
Table 153. Europe Rare Disease Drug Sales Quantity by Country (2025-2030) & (K Doses)
Table 154. Europe Rare Disease Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 155. Europe Rare Disease Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 156. Asia-Pacific Rare Disease Drug Sales Quantity by Type (2019-2024) & (K Doses)
Table 157. Asia-Pacific Rare Disease Drug Sales Quantity by Type (2025-2030) & (K Doses)
Table 158. Asia-Pacific Rare Disease Drug Sales Quantity by Application (2019-2024) & (K Doses)
Table 159. Asia-Pacific Rare Disease Drug Sales Quantity by Application (2025-2030) & (K Doses)
Table 160. Asia-Pacific Rare Disease Drug Sales Quantity by Region (2019-2024) & (K Doses)
Table 161. Asia-Pacific Rare Disease Drug Sales Quantity by Region (2025-2030) & (K Doses)
Table 162. Asia-Pacific Rare Disease Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 163. Asia-Pacific Rare Disease Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 164. South America Rare Disease Drug Sales Quantity by Type (2019-2024) & (K Doses)
Table 165. South America Rare Disease Drug Sales Quantity by Type (2025-2030) & (K Doses)
Table 166. South America Rare Disease Drug Sales Quantity by Application (2019-2024) & (K Doses)
Table 167. South America Rare Disease Drug Sales Quantity by Application (2025-2030) & (K Doses)
Table 168. South America Rare Disease Drug Sales Quantity by Country (2019-2024) & (K Doses)
Table 169. South America Rare Disease Drug Sales Quantity by Country (2025-2030) & (K Doses)
Table 170. South America Rare Disease Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 171. South America Rare Disease Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 172. Middle East & Africa Rare Disease Drug Sales Quantity by Type (2019-2024) & (K Doses)
Table 173. Middle East & Africa Rare Disease Drug Sales Quantity by Type (2025-2030) & (K Doses)
Table 174. Middle East & Africa Rare Disease Drug Sales Quantity by Application (2019-2024) & (K Doses)
Table 175. Middle East & Africa Rare Disease Drug Sales Quantity by Application (2025-2030) & (K Doses)
Table 176. Middle East & Africa Rare Disease Drug Sales Quantity by Region (2019-2024) & (K Doses)
Table 177. Middle East & Africa Rare Disease Drug Sales Quantity by Region (2025-2030) & (K Doses)
Table 178. Middle East & Africa Rare Disease Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 179. Middle East & Africa Rare Disease Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 180. Rare Disease Drug Raw Material
Table 181. Key Manufacturers of Rare Disease Drug Raw Materials
Table 182. Rare Disease Drug Typical Distributors
Table 183. Rare Disease Drug Typical Customers
LIST OF FIGURES
Figure 1. Rare Disease Drug Picture
Figure 2. Global Rare Disease Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Rare Disease Drug Consumption Value Market Share by Type in 2023
Figure 4. Above 1‰ Examples
Figure 5. 0.65‰?1‰ Examples
Figure 6. Below 0.1‰ Examples
Figure 7. Global Rare Disease Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 8. Global Rare Disease Drug Consumption Value Market Share by Application in 2023
Figure 9. Hospital Pharmacies Examples
Figure 10. Speciality Pharmacies Examples
Figure 11. Retail pharmacies Examples
Figure 12. Others Examples
Figure 13. Global Rare Disease Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Rare Disease Drug Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Rare Disease Drug Sales Quantity (2019-2030) & (K Doses)
Figure 16. Global Rare Disease Drug Average Price (2019-2030) & (USD/Dose)
Figure 17. Global Rare Disease Drug Sales Quantity Market Share by Manufacturer in 2023
Figure 18. Global Rare Disease Drug Consumption Value Market Share by Manufacturer in 2023
Figure 19. Producer Shipments of Rare Disease Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 20. Top 3 Rare Disease Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Top 6 Rare Disease Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Global Rare Disease Drug Sales Quantity Market Share by Region (2019-2030)
Figure 23. Global Rare Disease Drug Consumption Value Market Share by Region (2019-2030)
Figure 24. North America Rare Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 25. Europe Rare Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 26. Asia-Pacific Rare Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 27. South America Rare Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 28. Middle East & Africa Rare Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 29. Global Rare Disease Drug Sales Quantity Market Share by Type (2019-2030)
Figure 30. Global Rare Disease Drug Consumption Value Market Share by Type (2019-2030)
Figure 31. Global Rare Disease Drug Average Price by Type (2019-2030) & (USD/Dose)
Figure 32. Global Rare Disease Drug Sales Quantity Market Share by Application (2019-2030)
Figure 33. Global Rare Disease Drug Consumption Value Market Share by Application (2019-2030)
Figure 34. Global Rare Disease Drug Average Price by Application (2019-2030) & (USD/Dose)
Figure 35. North America Rare Disease Drug Sales Quantity Market Share by Type (2019-2030)
Figure 36. North America Rare Disease Drug Sales Quantity Market Share by Application (2019-2030)
Figure 37. North America Rare Disease Drug Sales Quantity Market Share by Country (2019-2030)
Figure 38. North America Rare Disease Drug Consumption Value Market Share by Country (2019-2030)
Figure 39. United States Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Canada Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Mexico Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Europe Rare Disease Drug Sales Quantity Market Share by Type (2019-2030)
Figure 43. Europe Rare Disease Drug Sales Quantity Market Share by Application (2019-2030)
Figure 44. Europe Rare Disease Drug Sales Quantity Market Share by Country (2019-2030)
Figure 45. Europe Rare Disease Drug Consumption Value Market Share by Country (2019-2030)
Figure 46. Germany Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. France Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. United Kingdom Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Russia Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Italy Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Asia-Pacific Rare Disease Drug Sales Quantity Market Share by Type (2019-2030)
Figure 52. Asia-Pacific Rare Disease Drug Sales Quantity Market Share by Application (2019-2030)
Figure 53. Asia-Pacific Rare Disease Drug Sales Quantity Market Share by Region (2019-2030)
Figure 54. Asia-Pacific Rare Disease Drug Consumption Value Market Share by Region (2019-2030)
Figure 55. China Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Japan Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Korea Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. India Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Southeast Asia Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Australia Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. South America Rare Disease Drug Sales Quantity Market Share by Type (2019-2030)
Figure 62. South America Rare Disease Drug Sales Quantity Market Share by Application (2019-2030)
Figure 63. South America Rare Disease Drug Sales Quantity Market Share by Country (2019-2030)
Figure 64. South America Rare Disease Drug Consumption Value Market Share by Country (2019-2030)
Figure 65. Brazil Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Argentina Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Middle East & Africa Rare Disease Drug Sales Quantity Market Share by Type (2019-2030)
Figure 68. Middle East & Africa Rare Disease Drug Sales Quantity Market Share by Application (2019-2030)
Figure 69. Middle East & Africa Rare Disease Drug Sales Quantity Market Share by Region (2019-2030)
Figure 70. Middle East & Africa Rare Disease Drug Consumption Value Market Share by Region (2019-2030)
Figure 71. Turkey Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Egypt Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Saudi Arabia Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. South Africa Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Rare Disease Drug Market Drivers
Figure 76. Rare Disease Drug Market Restraints
Figure 77. Rare Disease Drug Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Rare Disease Drug in 2023
Figure 80. Manufacturing Process Analysis of Rare Disease Drug
Figure 81. Rare Disease Drug Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Figure 1. Rare Disease Drug Picture
Figure 2. Global Rare Disease Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Rare Disease Drug Consumption Value Market Share by Type in 2023
Figure 4. Above 1‰ Examples
Figure 5. 0.65‰?1‰ Examples
Figure 6. Below 0.1‰ Examples
Figure 7. Global Rare Disease Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 8. Global Rare Disease Drug Consumption Value Market Share by Application in 2023
Figure 9. Hospital Pharmacies Examples
Figure 10. Speciality Pharmacies Examples
Figure 11. Retail pharmacies Examples
Figure 12. Others Examples
Figure 13. Global Rare Disease Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Rare Disease Drug Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Rare Disease Drug Sales Quantity (2019-2030) & (K Doses)
Figure 16. Global Rare Disease Drug Average Price (2019-2030) & (USD/Dose)
Figure 17. Global Rare Disease Drug Sales Quantity Market Share by Manufacturer in 2023
Figure 18. Global Rare Disease Drug Consumption Value Market Share by Manufacturer in 2023
Figure 19. Producer Shipments of Rare Disease Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 20. Top 3 Rare Disease Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Top 6 Rare Disease Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Global Rare Disease Drug Sales Quantity Market Share by Region (2019-2030)
Figure 23. Global Rare Disease Drug Consumption Value Market Share by Region (2019-2030)
Figure 24. North America Rare Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 25. Europe Rare Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 26. Asia-Pacific Rare Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 27. South America Rare Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 28. Middle East & Africa Rare Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 29. Global Rare Disease Drug Sales Quantity Market Share by Type (2019-2030)
Figure 30. Global Rare Disease Drug Consumption Value Market Share by Type (2019-2030)
Figure 31. Global Rare Disease Drug Average Price by Type (2019-2030) & (USD/Dose)
Figure 32. Global Rare Disease Drug Sales Quantity Market Share by Application (2019-2030)
Figure 33. Global Rare Disease Drug Consumption Value Market Share by Application (2019-2030)
Figure 34. Global Rare Disease Drug Average Price by Application (2019-2030) & (USD/Dose)
Figure 35. North America Rare Disease Drug Sales Quantity Market Share by Type (2019-2030)
Figure 36. North America Rare Disease Drug Sales Quantity Market Share by Application (2019-2030)
Figure 37. North America Rare Disease Drug Sales Quantity Market Share by Country (2019-2030)
Figure 38. North America Rare Disease Drug Consumption Value Market Share by Country (2019-2030)
Figure 39. United States Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Canada Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Mexico Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Europe Rare Disease Drug Sales Quantity Market Share by Type (2019-2030)
Figure 43. Europe Rare Disease Drug Sales Quantity Market Share by Application (2019-2030)
Figure 44. Europe Rare Disease Drug Sales Quantity Market Share by Country (2019-2030)
Figure 45. Europe Rare Disease Drug Consumption Value Market Share by Country (2019-2030)
Figure 46. Germany Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. France Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. United Kingdom Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Russia Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Italy Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Asia-Pacific Rare Disease Drug Sales Quantity Market Share by Type (2019-2030)
Figure 52. Asia-Pacific Rare Disease Drug Sales Quantity Market Share by Application (2019-2030)
Figure 53. Asia-Pacific Rare Disease Drug Sales Quantity Market Share by Region (2019-2030)
Figure 54. Asia-Pacific Rare Disease Drug Consumption Value Market Share by Region (2019-2030)
Figure 55. China Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Japan Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Korea Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. India Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Southeast Asia Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Australia Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. South America Rare Disease Drug Sales Quantity Market Share by Type (2019-2030)
Figure 62. South America Rare Disease Drug Sales Quantity Market Share by Application (2019-2030)
Figure 63. South America Rare Disease Drug Sales Quantity Market Share by Country (2019-2030)
Figure 64. South America Rare Disease Drug Consumption Value Market Share by Country (2019-2030)
Figure 65. Brazil Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Argentina Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Middle East & Africa Rare Disease Drug Sales Quantity Market Share by Type (2019-2030)
Figure 68. Middle East & Africa Rare Disease Drug Sales Quantity Market Share by Application (2019-2030)
Figure 69. Middle East & Africa Rare Disease Drug Sales Quantity Market Share by Region (2019-2030)
Figure 70. Middle East & Africa Rare Disease Drug Consumption Value Market Share by Region (2019-2030)
Figure 71. Turkey Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Egypt Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Saudi Arabia Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. South Africa Rare Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Rare Disease Drug Market Drivers
Figure 76. Rare Disease Drug Market Restraints
Figure 77. Rare Disease Drug Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Rare Disease Drug in 2023
Figure 80. Manufacturing Process Analysis of Rare Disease Drug
Figure 81. Rare Disease Drug Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
